|
13vPCV
|
13-valent pneumococcal conjugate vaccine
|
|
23vPPV
|
23-valent pneumococcal polysaccharide vaccine
|
|
ABI
|
Ankle–brachial pressure index
|
|
ACE
|
Angiotensin-converting enzyme
|
|
ACEi
|
Angiotensin-converting enzyme inhibitor
|
|
ACR
|
Albumin-to-creatinine ratio
|
|
ADA
|
American Diabetes Association
|
|
ADEA
|
Australian Diabetes Educators Association
|
|
ADIPS
|
Australian Diabetes in Pregnancy Society
|
|
ADS
|
Australian Diabetes Society
|
|
AGP
|
Ambulatory glucose profile
|
|
AIHW
|
Australian Institute of Health and Welfare
|
|
APD
|
Accredited practising dietitian
|
|
ARB
|
Angiotensin receptor blocker
|
|
AUSDRISK
|
Australian type 2 diabetes risk assessment tool
|
|
BGL
|
Blood glucose level
|
|
BMI
|
Body mass index
|
|
BP
|
Blood pressure
|
|
CCM
|
Chronic care model
|
|
CDE
|
Credentialled diabetes educator
|
|
CGM
|
Continuous glucose monitoring
|
|
CKD
|
Chronic kidney disease
|
|
CrCI
|
Creatinine clearance
|
|
CSII
|
Continuous subcutaneous insulin infusion
|
|
CVD
|
Cardiovascular disease
|
|
DDS
|
Diabetes Distress Scale
|
|
DiRECT
|
Diabetes Remission Clinical Trial
|
|
DKA
|
Diabetic ketoacidosis
|
|
DOAC
|
Direct oral anticoagulant
|
|
DPP-4i
|
Dipeptidyl peptidase-4 inhibitor
|
|
DR
|
Diabetes-related retinopathy
|
|
eGDM
|
Early gestational diabetes
|
|
dTpa
|
Diphtheria-tetanus-acellular pertussis
|
|
eGFR
|
Estimated glomerular filtration rate
|
|
FBG
|
Fasting blood glucose
|
|
FlashGM
|
Flash glucose monitoring
|
|
FPG
|
Fasting plasma glucose
|
|
FITTER
|
Forum for Injection Technique and Therapy Expert Recommendations
|
|
GAD
|
Glutamic acid decarboxylase
|
|
G-CSF
|
Granulocyte colony-stimulating factor
|
|
GDM
|
Gestational diabetes
|
|
GI
|
Glycaemic index
|
|
GLP-1
|
Glucagon-like peptide-1
|
|
GLP-1RA
|
Glucagon-like peptide-1 receptor agonist
|
|
GP
|
General practitioner
|
|
GPMP
|
GP management plan
|
|
HAPO
|
Hyperglycemia and Adverse Pregnancy Outcome study
|
|
HbA1c
|
Glycated haemoglobin
|
|
HDL-C
|
High-density lipoprotein cholesterol
|
|
HHS
|
Hyperosmolar hyperglycaemic state
|
|
HIV
|
Human immunodeficiency virus
|
|
IA-2
|
Insulinoma antigen-2
|
|
ICHOM
|
International Consortium for Health Outcomes Measurement
|
|
IDSA
|
Infectious Diseases Society of America
|
|
IFCC
|
International Federation of Clinical Chemistry
|
|
IFG
|
Impaired fasting glucose
|
|
IGT
|
Impaired glucose tolerance
|
|
IUCD
|
Intrauterine contraceptive device
|
|
IWGDF
|
International Working Group on Diabetic Foot
|
|
LADA
|
Latent autoimmune diabetes of adults
|
|
LAGB
|
Laparoscopic adjustable gastric banding
|
|
LDL-C
|
Low-density lipoprotein cholesterol
|
|
MBS
|
Medicare Benefits Schedule
|
|
MI
|
Myocardial infarction
|
|
MALFD
|
Metabolic-associated fatty liver disease
|
|
NDSS
|
National Diabetes Services Scheme
|
|
NHMRC
|
National Health and Medical Research Council
|
|
NICE
|
National Institute for Health and Care Excellence
|
|
NSAID
|
Non-steroidal anti-inflammatory drug
|
|
OGTT
|
Oral glucose tolerance test
|
|
OSA
|
Obstructive sleep apnoea
|
|
PAD
|
Peripheral arterial disease
|
|
PAID
|
Problem Areas in Diabetes
|
|
PBS
|
Pharmaceutical Benefits Scheme
|
|
PCOS
|
Polycystic ovary syndrome
|
|
PCSK9
|
Proprotein convertase subtilisin/kexin type 9
|
|
PHN
|
Primary health network
|
|
PHQ-2
|
Patient Health Questionnaire-2
|
|
PHQ-9
|
Patient Health Questionnaire-9
|
|
QEBR
|
Qualified evidence-based recommendation
|
|
RACGP
|
The Royal Australian College of General Practitioners
|
|
RBG
|
Random blood glucose
|
|
RCT
|
Randomised controlled trial
|
|
RPE
|
Rate of perceived exertion
|
|
RR
|
Relative risk
|
|
SGLT2
|
Sodium–glucose cotransporter 2
|
|
SGLT2i
|
Sodium–glucose cotransporter 2 inhibitor
|
|
SIGN
|
Scottish Intercollegiate Guidelines Network
|
|
SINBAD
|
Site, Ischaemia, Neuropathy, Bacterial infection, Area, Depth
|
|
SMBG
|
Self-monitoring of blood glucose
|
|
SNAP
|
Smoking, nutrition, alcohol, physical activity
|
|
TBI
|
Toe–brachial index
|
|
TGA
|
Therapeutic Goods Administration
|
|
TZD
|
Thiazolidinedione
|
|
UACR
|
Urine albumin-to-creatinine ratio
|
|
VEGF
|
Vascular endothelial growth factor
|
|
VLED
|
Very-low-energy diet
|